Discogen and DiscRx™: Exploring a New Noninvasive Approach to Discogenic Low Back Pain

Written By Peter A. Zahos

Low back pain remains one of the leading causes of disability worldwide, affecting millions of patients and placing a substantial burden on healthcare systems. While traditional treatments—including medications, injections, and surgery—play an important role, many focus on managing symptoms rather than addressing the underlying biology of disc degeneration.

In a recent episode of The Life Medical Podcast, titled “Discogen: A New Treatment for Low Back Pain,” neurosurgeon Dr. Peter Zahos explores an emerging, noninvasive investigational approach aimed at the early stages of discogenic back pain—a condition that often progresses silently until surgical intervention becomes unavoidable.

Understanding Discogenic Low Back Pain

Discogenic back pain arises from degeneration of the intervertebral discs, which can lose hydration, structural integrity, and normal biochemical balance over time. As degeneration progresses, inflammatory signaling and mechanical dysfunction contribute to chronic pain, reduced mobility, and declining quality of life.

One of the major challenges in spine care is that by the time symptoms become severe, biologic repair options may no longer be viable, leaving surgery as the primary solution. This reality has fueled growing interest in therapies that intervene earlier in the disease process.

What Is Discogen and DiscRx™?

During the podcast discussion, Dr. Zahos introduces Discogen, a medical technology development company focused on therapies for discogenic back pain, and its investigational platform DiscRx™.

DiscRx™ is designed as a noninvasive therapeutic approach intended to:

  • Promote tissue remodeling and repair within early degenerative discs

  • Reduce inflammatory signaling associated with disc disease

  • Support biologic processes that may slow disease progression

  • Provide symptomatic relief while addressing underlying pathology

Rather than compensating for disc degeneration mechanically, DiscRx™ aims to support intrinsic repair mechanisms within the disc—an approach that may be particularly relevant for patients with early- to mid-stage degeneration.

The Science Behind the Concept

The podcast highlights the translational science that informed Discogen’s development strategy, including preclinical and laboratory research examining low-intensity pulsed ultrasound (LIPUS) as a biologic stimulus.

Preclinical studies have demonstrated that targeted, low-energy ultrasound can:

  • Increase expression of key extracellular matrix components, such as collagen type II

  • Decrease inflammatory mediators linked to disc degeneration

  • Stimulate anabolic cellular responses without thermal tissue injury

These findings form the scientific foundation for DiscRx™ as a regenerative-oriented, noninvasive strategy, while reinforcing the importance of rigorous validation before widespread clinical adoption.

What This Could Mean for Patients

For patients with early-stage disc degeneration, a therapy that safely delays progression could have meaningful long-term implications. As discussed on the podcast, delaying surgery—even by several years—has the potential to:

  • Preserve spinal motion and function longer

  • Reduce the likelihood of adjacent-level disease

  • Decrease the need for additional surgical procedures over a lifetime

Importantly, Dr. Zahos emphasizes that DiscRx™ is not intended to replace surgery, but rather to expand the treatment continuum for appropriately selected patients before irreversible structural damage occurs.

Innovation with Clinical Discipline

A central theme of the episode is balance. Innovation in spine care must be paired with:

  • Careful patient selection

  • Scientific rigor and controlled evaluation

  • Transparency about benefits, limitations, and appropriate use

This disciplined approach reflects Dr. Zahos’s broader philosophy as both a neurosurgeon and podcast host: advancing the field responsibly matters as much as advancing it quickly.

Listen to the Episode

“Discogen: A New Treatment for Low Back Pain” is available on major streaming platforms, including Spotify, Pandora, and Amazon Music.

For patients, clinicians, and researchers alike, the episode offers a thoughtful look at where disc care may be headed—and how biologic innovation could reshape the future of spine treatment.

Peter A. Zahos
Next

Dr. Peter A. Zahos Named 2025 New Jersey Monthly Top Doctor: A Commitment to Clinical Excellence and Patient-Centered Neurosurgery